SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-029954
Filing Date
2009-06-01
Accepted
2009-06-01 17:48:49
Documents
1
Period of Report
2009-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4077
  Complete submission text file 0001209191-09-029954.txt   6004
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Issuer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORNERSTONE BIOPHARMA HOLDINGS, INC. 2000 REGENCY PARKWAY, SUITE 255 CARY NC 27518
Business Address
Price David (Reporting) CIK: 0001449336 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50767 | Film No.: 09866147